Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Impact of Rapid Pathogen Identification From Blood Cultures (RABbIT - Rapid Blood Culture Intervention Trial)

NCT02743585 is registered in ClinicalTrials.gov with Tan Tock Seng Hospital as lead sponsor.

NCT NCT02743585
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02743585 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Impact of Rapid Pathogen Identification From Blood Cultures (RABbIT - Rapid Blood Culture Intervention Trial)
Lead sponsor
Tan Tock Seng Hospital
Phase
Not applicable
Overall status
Unknown status
Start date
March 20, 2017
Completion date
July 2, 2020
Enrollment
832 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bacteremia, blood stream infection, fungemia, sepsis